Cargando…
Vaso‐occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease (COVID‐19)
Autores principales: | Nur, Erfan, Gaartman, Aafke E., van Tuijn, Charlotte F. J., Tang, Man Wai, Biemond, Bart J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262303/ https://www.ncbi.nlm.nih.gov/pubmed/32267016 http://dx.doi.org/10.1002/ajh.25821 |
Ejemplares similares
-
Fluid overload due to intravenous fluid therapy for vaso‐occlusive crisis in sickle cell disease: incidence and risk factors
por: Gaartman, Aafke E., et al.
Publicado: (2021) -
Incentive spirometry to prevent acute chest syndrome in adults with sickle cell disease; a randomized controlled trial
por: van Tuijn, Charlotte F.J., et al.
Publicado: (2020) -
P1450: VOXELOTOR TREATMENT LEADS TO IMPROVED VIABILITY OF SICKLE ERYTHROCYTES
por: Konté, Kadère, et al.
Publicado: (2023) -
Incidence of Sars-COV-2 Infection in Sickle Cell Patients Presenting with a Painful Crisis, a 12 Month Prospective Cohort Study
por: Konté, Kadère, et al.
Publicado: (2021) -
Incidence of SARS‐COV‐2 infection in sickle cell patients presenting with a painful crisis: A 12‐month prospective cohort study
por: Konté, Kadère, et al.
Publicado: (2021)